Why is Research Focused on Black Patients in Glaucoma Essential?

Glaucoma is an eye disease that causes damage to the optic nerve, leading to progressive vision loss. This condition disproportionately affects patients of African descent, where it can be seen in much younger patients and with increased severity (1). Despite the increased prevalence in this sub-population, most of the leading research used to inform treatment guidelines predominantly involves Caucasians. It leads us to ask: are Black patients truly being treated with evidence-based medicine, or are we relying on evidence that has been extrapolated from non-Black populations?